Chemistry
195Pt NMR Spectroscopy
35%
1D NMR Spectroscopy
11%
3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium Bromide
12%
Albumin
13%
Antiproliferative
32%
Antitumor
29%
Capillar Electrophoresis
30%
Capillary Zone Electrophoresis
11%
Carboplatin
17%
Carboxamide
13%
chelate
17%
Cisplatin
83%
Coordination Sphere
17%
Crystal Structure
39%
Culture Media
11%
cyclohexane-1,2-diamine
20%
Derivatization
12%
DNA
37%
Electrospray Ionization Mass Spectrometry
37%
Electrospray Ionization Mass Spectroscopy
44%
Elemental Analysis
41%
Enzymatic Hydrolysis
18%
Ethanolamine
14%
Ethylamine
17%
Ferrocene
23%
formation
40%
GMP
46%
Guanosine
22%
High Performance Liquid Chromatography
14%
IC50
46%
Indazole
11%
Inductively Coupled Plasm Mass Spectrometry (ICPMS)
21%
Inductively Coupled Plasma Method
17%
Lipophilicity
52%
Liquid Chromatography
11%
Microemulsion Electrokinetic Chromatography
13%
MTT Assay
20%
Nitrile
20%
NMR Spectroscopy
77%
Oxaliplatin
33%
Oxazoline
11%
Oxime
18%
Prodrug
47%
Reduction Potential
11%
Ruthenium
17%
Spectroscopy
11%
stability
21%
Tris
11%
Two-Dimensional NMR
21%
X-Ray Diffraction
30%
Pharmacology, Toxicology and Pharmaceutical Science
1,2 Diaminocyclohexane
7%
Antitumor Activity
7%
Ascorbic Acid
7%
Buffer
6%
Capillary Electrophoresis
12%
Carbon 13
13%
Carboplatin
13%
Carboxamide
9%
Chitosan
5%
Cisplatin
44%
Cyclohexane
19%
Cytotoxicity
100%
Dendrimer
11%
Dicarboxylic Acid
6%
Dimethyl Sulfoxide
7%
Electrospray Ionization
6%
Elemental Analysis
15%
Fourier Transform Infrared Spectroscopy
5%
Guanine
5%
Guanosine Phosphate
25%
High Performance Liquid Chromatography
9%
Human Serum Albumin
7%
Hypoxia
6%
IC50
10%
Indazole Derivative
6%
Inductively Coupled Plasma
33%
Lipophilicity
24%
Metal Complex
7%
Neoplasm
49%
Nitrogen 15
8%
Non Small Cell Lung Cancer
6%
Octanol
12%
Oxaliplatin
41%
Paullone
5%
Pentetic Acid
5%
Plasma Protein
5%
Platinum
47%
Platinum Complex
21%
Poly(amidoamine)
11%
Prodrug
33%
Protein Binding
6%
Reducing Agent
6%
Ruthenium Complex
5%
Satraplatin
8%
Solid Malignant Neoplasm
12%
Stable Isotope
5%
Structure Activity Relationship
13%
Targeted Drug Delivery
5%
Therapeutic Effect
5%
Tumor Model
6%
